 - Any evidence of or history, elicited by the investigator, of symptomatic cerebrovascular events i.e., stroke or transient ischemic attack within 6 months prior to study entry; or any history or evidence of pulmonary embolism or thrombophlebitis including deep vein thrombosis requiring anticoagulant therapy e.g., warfarin or heparin. 